Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated 13 minutes ago
CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
13 minutes ago
The company chalks up a finanical impact of about 150 billion Korean...
After March cuts, Novartis trims another 60 roles at US headquarters
33 minutes ago
After submitting plans to cut 114 jobs tied to its U.S. headquarters...
Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
about 2 hours ago
Bristol Myers Squibb is warming up for the FIFA World Cup 2026...
Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
about 3 hours ago
After topping up its long-running operations in Puerto Rico last year, Amgen...
GLP-1 boom pushes oncology off top spot for late-stage pipeline value: Deloitte
about 5 hours ago
For the first time in its 16-year analysis of the pharma industry...
Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
about 9 hours ago
Rising Stars: A strategic marketing lead at CDMO Axplora, Arsalan Khan is...
FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
3 days ago
The early FDA approval doesn't change Pfizer and Arvinas' plan to leave...
Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
3 days ago
Four years after gaining FDA approval for Auvelity to treat major depressive...
Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
3 days ago
Shortly after laying out $75 million upfront for Corstasis Therapeutics and its...
Union workers at Korean CDMO Samsung Biologics kick off strike
3 days ago
The company looks to achieve an "amicable resolution as soon as possible"...
Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
3 days ago
A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has...
FDA expectations create potential friction in new Form 483 response guidance
3 days ago
Looking to clarify its expectations on manufacturer responses following inspections, the FDA...